Doxazosin Mesylate, Extended Release
W81XWH-17-1-0234
Phase 2 small_molecule active
Quick answer
Doxazosin Mesylate, Extended Release for Stress Disorders, Post-Traumatic is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Stress Disorders, Post-Traumatic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active